Last reviewed · How we verify

NCT05139589: ENDO_AUMC

The ENDOCARDITIS AUMC Data Collection

Recruiting now Last updated 25 July 2023
What this trial tests

trial testing None, observational in Endocarditis in 3,000 participants. Currently enrolling.

Timeline
6 August 2023
Primary endpoint
31 December 2030
31 December 2030

Quick facts

Lead sponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment3,000
Start date6 August 2023
Primary completion31 December 2030
Estimated completion31 December 2030
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) — full company profile →

Who can join

18 and older, any sex, with Endocarditis or Coagulation Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will compare patients with and without infective ndocarditis undergoing valve surgery and evaluate factors that may help optimise perioperative care of these high-risk patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endocarditis

Currently open trials in the same condition.

Other Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05139589.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing